Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Mar 08, 2024 9:57am
90 Views
Post# 35922498

Go Shop Period - One More week to Go

Go Shop Period - One More week to GoTHNK's stock is still trading very near the Beedie bid but very few shares are being offered (the market Ask on THNK stock is only about 300,000 shares at 0.32 cents). With 5 NDA's signed investors continue to anticipate another bid. Even if another bid doesn't materialize valuations in the market have gone up considerably over the past few weeks which further underscores that Beedie's offer is very low-ball in nature.

In conversations with other investors I'm increasingly getting the sense that this isn't a done deal, as in if the current Beedie offer is all that ends up being on the table it may not get shaeholder approval. I guess we'll see but I'm still of the opinion that next week could be very positive for shareholders with potentially 1-2 bidders emerging offering a price considerably above the current offer. There is an outside chance an offer could come in today but bidders still have time to complete their diligence so mid or late next week seems more likely.
<< Previous
Bullboard Posts
Next >>